NEW DELHI: The Coalition for Epidemic Preparedness Innovations (CEPI) has announced an agreement with a consortium comprising International Vaccine Institute and Hyderabad-based vaccine major Bharat Biotech for development of a chikungunya vaccine, reports Surendra Singh. CEPI ill fund the consortium with up to $14.1 million (approx. Rs 105 crore) for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine against chikRead More – Source
[contf]
[contfnew]
times of india
[contfnewc]
[contfnewc]
